Thalidomide-NH-CH2-CONH-C6-Br

CAT:

804-HY-168291

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

UNSPSC Description: Thalidomide-NH-CH2-CONH-C6-Br is an E3 ligase ligand-linker conjugate that can be used to synthesize DD-03-171 (HY-122830)[1].
Target Antigen: E3 Ligase Ligand-Linker Conjugates
Type: Reference compound
Related Pathways: PROTAC
Applications: Cancer-programmed cell death
Field of Research: Cancer
Assay Protocol: https://www.medchemexpress.com/thalidomide-nh-ch2-conh-c6-br.html
Smiles: O=C(NCCCCCCBr)CNC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O
Molecular Weight: 493.35
References & Citations: [1]Dennis Dobrovolsky, et al. Bruton’s Tyrosine Kinase Degradation as a Therapeutic Strategy for Cancer. Blood. 2019 Feb 28;133(9):952-961.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-168291	Thalidomide-NH-CH2-CONH-C6-Br
HY-169397	Thalidomide-NH-CH2-CONH-C2-PEG-bromine
HY-131717-02	Thalidomide-NH-CH2-COOH
HY-131717-01	Thalidomide-NH-CH2-COOH
HY-163826	Benzothiazole-CH2(NH-CO-CH2Cl)-CONH-CH2-Ph
HY-130854-01	Thalidomide-NH-C6-NH-Boc
HY-130854-02	Thalidomide-NH-C6-NH-Boc
HY-W584515	Thalidomide-NH-(CH2)3-NH-Boc
HY-W584513	Thalidomide-NH-(CH2)2-NH-Boc
HY-129704	Thalidomide-NH-C6-NH2